6
Oct
2026

HANA PHARM. CO., LTD.

Exhibitor at CPHI Milan 2026 stand 8J64, Contract Manufacturing & Services
About Us

We develop products with the highest priority for patients and will lead the way in improving human health and quality of life.Above all, we have achieved sustained growth based on anesthetics and narcotic analgesics, in which we are recognized as the No.1 company in Korea.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2025
  • Employees:
    500 - 999
Company types
Pharmaceutical company
View company profile
Contact info
  • 01027327634
  • Website
  • Teheran-ro 407, Gangnam-gu, EK tower 10F, 06162, Seoul, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 8J64, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Dexmedetomidine HCI

    Product Dexmedetomidine HCI

    -Active Ingredients: Dexmedetomidine HCI -Dosage: 200mcg/2mL -Indication Sedation under intensive care management Conscious sedation for non-intubated patients during surgery and procedures -GMP: Korea GMP -Stability: Zone IV b
  • Isoflurane

    Product Isoflurane

    -Active Ingredients: Isoflurane -Dosage: 100mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b
  • Propofol

    Product Propofol

    -Active Ingredients: Propofol -Dosage: 120mg/12mL, 200mg/20mL -Indication Induction and maintenance of general anesthesia Sedation of ventilated patients receiving intensive care Sedation of surgical and diagnostic procedures -GMP: Korea GMP -Stability: Zone IV b
  • Remimazolam

    Product Remimazolam

    -Active Ingredients: Remimzaolam Bsylate -Excipients: Dextran 40, Lactose monohydrate, sodium hydroxide, hydrochloric acid -Dosage: 20mg, 50mg -Indication: 1. Byfavo Inj. 20mg The induction and maintenance of general anesthesia The induction and maintenance of procedural sedation in adults undergoing proce...
  • Sevoflurane

    Product Sevoflurane

    -Active Ingredients: Sevoflurane -Dosage: 250mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b